Critical COVID-19 disease explained by type I interferon autoantibodies found in patients within the Military Health System

Andrew L. Snow(Uniformed Services University of the Health Sciences), Anuradha Ganesan, Timothy Burgess(Uniformed Services University of the Health Sciences), Stephanie A Richard(Henry M. Jackson Foundation), Evan Ewers(Alexander T. Augusta Military Medical Center), Katrin Mende, Eric D. Laing(Uniformed Services University of the Health Sciences), Tahaniyat Lalani(Henry M. Jackson Foundation), Paul Bastard(Inserm), Helen C. Su(National Institute of Allergy and Infectious Diseases), Catherine M Berjohn(Henry M. Jackson Foundation), Ryan C. Maves(Naval Medical Center San Diego), Nikhil Huprikar(Uniformed Services University of the Health Sciences), Rupal Mody(William Beaumont Army Medical Center), Derek Larson(Alexander T. Augusta Military Medical Center), Elana Shaw, E Samuels(Uniformed Services University of the Health Sciences), Jean‐Laurent Casanova(Howard Hughes Medical Institute), Mark P. Simons(Uniformed Services University of the Health Sciences), Steven M. Holland(National Institute of Allergy and Infectious Diseases), Debra Yee(National Institutes of Health), Lindsey B. Rosen(National Institute of Allergy and Infectious Diseases), Milissa U. Jones(Uniformed Services University of the Health Sciences), Rhonda E Colombo(Henry M. Jackson Foundation), David A Lindholm(Uniformed Services University of the Health Sciences), Marana S Tso(Uniformed Services University of the Health Sciences), David R. Tribble(Uniformed Services University of the Health Sciences), Christopher Colombo(Madigan Army Medical Center), Maria Leondaridis(Uniformed Services University of the Health Sciences), Brian K. Agan(Henry M. Jackson Foundation), Simon Pollett(Henry M. Jackson Foundation)
The Journal of Immunology
May 1, 2023
Cited by 0


Related Papers